A model of genital Chlamydia trachomatis infection using human xenografts in severe combined immunodeficiency mice

Infection and Immunity

Volumn 64, Issue 6, 1996, Pages 2300-2307

  Essig, Andreas ^a   Rudolphi, Angelika ^a   Heinemann, Markus ^a   Rosenthal, Heike ^a   Kaufmann, Roland ^b   Reimann, Jörg ^a   Marre, Reinhard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDIA TRACHOMATIS; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HOST PARASITE INTERACTION; HOST SUSCEPTIBILITY; HUMAN; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STRAIN DIFFERENCE; XENOGRAFT;

EID: 0029886708     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.6.2300-2307.1996     Document Type: Article

References (32)

1. Arno, J. N., V. A. Ricker, B. E. Batteiger, B. P. Katz, V. A. Caine, and R. B. Jones. 1990. Interferon-γ in endocervical secretions of women infected with Chlamydia trachomatis. J. Infect. Dis. 162:1385-1389.
2. Barron, A. L., R. G. Rank, and E. B. Moses. 1984. Immune response in mice infected in the genital tract with mouse pneumonitis agent (Chlamydia trachomatis biovar). Infect. Immun. 44:82-85.
3. Barron, A. L., H. J. While, R. G. Rank, B. L. Soloff, and E. B. Moses. 1981. A new animal model fur the study of Chlamydia trachomatis genital infections: infection of mice with the agent of mouse pneumonitis. J. Infect. Dis. 143:63-66.
4. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998-4002.
5. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
6. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1995. Reactivation of persistent CMamydia trachomatis infection in cell culture. Infect. Immun. 63: 199-205.
7. Blander, S. J., and A. J. Amortegui. 1994. Mice immunized with a chlamydial extract have no increase in early protective immunity despite increased inflammation following genital infection by the mouse pneumonitis agent of CMamydia trachomatis. Infect. Immun. 62:3617-3624.
8. Bosma, M. J., and A. M. Carroll. 1991. The scid mouse mutant: definition, characterization and potential uses. Annu. Rev. Immunol. 9:323-350.
9. Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31:1161-1176.
10. Campbell, S., S. J. Richmond, P. Haynes, D. Gump, P. Yates, and T. D. Allen. 1988. An in vitro model of Chlamydia trachomatis infection in the regenerative phase of the human endometrial cycle. J. Gen. Microbiol. 134:2077-2087.
11. Fu, Y., M. Baumann, P. Kosma, L. Brade, and H. Brade. 1992. A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same immunoreactivity as its natural counter-part. Infect. Immun. 60:1314-1321.
12. + T cells in antichlamydial immunity defined by chlamydia-specific T-lymphocyte clones. Infect. Immun. 62:5195-5197.
13. Ito, J. I., H. Harrison, E. R. Alexander, and L. J. Billings. 1984. Establishment of female genital tract infection in the CF-1 mouse by intravaginal inoculation of a human oculogenital isolate of Chlamydia trachomatis. J. Infect. Dis. 150:577-582.
14. Jantos, C., W. Baumgärtner, B. Durchfeld, and H. G. Schiefer. 1992. Experimental epididymitis due to Chlamydia trachomatis in rats. Infect. Immun. 60:2324-2328.
15. Kaufmann, R., V. Mielke, J. Reimann, C. E. Klein, and W. Sterry. 1993. Cellular and molecular composition of human skin xenografls on SCID-mice. Exp. Dermatol. 2:209-216.
16. Kaufmann, R., A. Rudolphi, H. J. Boxberger, A. Hainzl, H. Rosenthal, and J. Reimann. 1995. Stable engraftment of human female genital mucous membrane xenografts on SCID mice. Gynecol. Obstet. Invest. 40:97-100.
17. Landers, D. V., K. Erlich, M. Sung, and J. Schachter. 1991. Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis. Infect. Immun. 59:3774-3777.
18. Maslow, A. S., C. H. Davis, J. Choong, and P. B. Wyrick. 1988. Estrogen enhances attachment of Chlamydia trachomatis to human endometrial epithelial cells in vitro. Am. J. Obstet. Gynecol. 159:1006-1014.
19. Mayer, J., M. L. Woods, Z. Vavrin, and J. B. Hibbs, Jr. 1993. Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells. Infect. Immun. 61:491-497.
20. McDermott, M. R., D. A. Clark, and J. Bienstock. 1980. Evidence for a common mucosal immunological system. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J. Immunol. 124: 2536.
21. Moorman, D. R., J. W. Sixbey, and P. B. Wyrick. 1986. Interaction of Chlamydia trachomatis with human genital epithelium in culture. J. Gen. Microbiol. 132:1055-1067.
22. Moulder, J. W. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190.
23. Patton, D. L., C. C. Kuo, and R. M. Brenner. 1989 Chlamydia trachomatis oculogenital infection in the subcutaneous autotransplant model of conjunctiva, salpinx and endometrium. Br. J. Exp. Pathol. 70:357-367.
24. Rank, R. G., and M. M. Sanders. 1992. Pathogenesis of endometritis and salpingitis in a guinea pig model of chlamydial genital infection. Am. J. Pathol. 140:927-936.
25. Raulston, J. E. 1995. Chlamydial envelope components and pathogen-host cell interactions. Mol. Microbiol. 15:607-616.
26. Shemer-Avni, Y., D. Wallach, and J. Sarov. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56:2503-2506.
27. Sweet, R. L., M. Blankfort-Doyle, M. O. Robbie, and J. Schachter. 1986. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 255:2062-2064.
28. Weiss, E., S. Schramek, N. N. Wilson, and L. W. Newman. 1970. Desoxyribonucleic acid heterogeneity between human and murine strains of Chlamydia trachomatis. Infect. Immun. 2:24-28.
29. Williams, D. M., B. G. Grubbs, J. Schachter, and D. M. Magee. 1993. Gamma Interferon levels during Chlamydia trachomatis pneumonia in mice. Infect. Immun. 61:3556-3558.
30. Williams, D. M., D. M. Magee, L. F. Bonewald, J. G. Smith, C. H. Bleicker, G. I. Byrne, and J. Schachter. 1990. A role in vivo for tumor necrosis factor alpha in host defense against Chlamydia trachomatis. Infect. Immun. 58: 1572-1576.
31. Wyrick, P. B., J. Choong, C. H. Davis, S. T. Knight, M. O. Royal, A. S. Maslow, and C. R. Bagnell. 1989. Entry of genital Chlamydia trachomatis into polarized human epithelial cells. Infect. Immun. 57:2378-2389.
32. Zhong, G., E. M. Peterson, C. W. Czarniecki, R. D. Schreiber, and L. M. de La Maza. 1989. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect. Immun. 57:152-157.